COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc (CBIS) announced today the appointment of Dorothy Bray, Ph.D., Former Global Director of HIV Research and Senior Clinical Program Head of HIV and Opportunistic Infections for GlaxoSmithKline, to the Company’s Scientific Advisory Board.
